Recent APS Webinar Recordings

From May 12th 2021.

Drug Design and Developement

ARPAN DESAI, Astra Zeneca- Design and Delivery methods for gene therapies

CHRISTINE DUFES, Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) Glasgow-Development of gene-based nanomedicines for cancer therapy

CHRIS VAN DER WALLE, GlaxoSmithKline- Formulation considerations for T-cell therapies

From April 29th 2021.

“Phenotypic nanomedicines: integrating personalised medicine into drug delivery”

Prof Giuseppe Battaglia-ICREA Research Professor, Chair of Molecular Bionics,Institute for Bioengineering of Catalonia, Barcelona Institute of Science and Technology. Department of Chemistry, Institute for the Physics of Living Systems, University College London

From January 19th 2021.

“Clinically Relevant Dissolution Specifications – Why, What, and How ?”

Dr Paul Dickinson – SEDA Pharmaceutical Development Services and Dr Andreas Abend – MSD

From May 18th 2021.

Overview of global regulatory trends within CRDS including progress, challenges and emerging opportunities

Om Anand- FDA & Aris Dokoumetzidis-University of Athens (Greece)

From September 30th 2020.

Ameliorating the gut microbiome for longevity and healthy ageing ​ –

Laura McCoubrey​-UCL School of Pharmacy

The Gut Microbiome and drug interactions: Biopharmaceutical and oral bioavailability considerations –

Dr Brendan Griffin-University College Cork

From November 19th 2020.

Drug Development in Age-Related Medicines and Challenges in Low and Middle Income Countries (LMICs): An academic and pharmaceutical industry perspective

Professor Trevor Jones-Founder member of Medicines for Malaria Venture (MMV) -Director Arix Bioscience plc,Former R&D Director, Wellcome Foundation

Dr Bahijja Raimi-Abraham-Lecturer in Pharmaceutics King’s College London Fight the Fakes Founder and Academic Lead.